Our analysis shows that along with wild-type TP53 and p16 overexpression, HPV-positive tumours were less likely to carry gene amplification of chromosomal band 11q13, which further defines the characteristic of HPV-positive head and neck tumours and suggests a distinct molecular pathway for HNSCC development. The gene discussed is CDKN2A; the disease is head and neck neoplasm.